Scoop has an Ethical Paywall
Licence needed for work use Learn More

Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

NZ bioinformatics company hits No1 on Apple site

NZ bioinformatics company hits No1 on Apple website

AUCKLAND, 21 April 2006: A new bioinformatics product launched by New Zealand company Biomatters has gone straight to first place as the most downloaded software on Apple’s Math and Science website in just two days.

“It’s becoming clear our development team have created something special,” said Daniel Batten, CEO of Biomatters, whose Geneious 1.0 software was launched on Wednesday.

“The high download rate matches the already positive endorsement we have had on the beta version of Geneious from scientists all over the world.”

Geneious 1.0 greatly simplifies and speeds up bioinformatics tasks including sequence alignment using publicly accessible genetic databases now accessed by over one million researchers.

The beta version was quickly adopted for university courses in Germany and Australia and made its debut in the top three of Apple’s “Hot Picks”.

Among many researchers around the world who welcomed it as “long awaited”, Professor Stefan Könemann at the University of Veterinary Medicine in Hannover in Germany said his students,”unanimously voted Geneious as the best for ease of use.”

Geneious is being developed by a team led by Dr Alexei Drummond.

Mr Batten said they aim to develop software that will contribute to significantly speeding up research and identification of potential new treatments.

Researchers can download Geneious 1.0 free at www.geneious.com.

Biomatters plans to release a commercial version, Geneious Pro, later this year.

ENDS

Advertisement - scroll to continue reading

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Business Headlines | Sci-Tech Headlines

 
 
 
 
 
 
 
 
 
 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.